Luseogliflozin (TS 071) is a potent, selective, orally active sodium-dependent glucose cotransporter ( SGLT ) 2 inhibitor, with an IC 50 of 2.26 nM, about 1765-fold selectivity over SGLT1 ( IC 50 , 3990 nM). Luseogliflozin has the protential for researching type 2 diabetes.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > SGLT
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.